Previously when the company spoke about Lympro or the Diagnostic division it was we "may" spinout or "considering". Now it looks a little more certain with "now preparing" and just Lympro. Diagnostic division spinout/divestiture wasn't mentioned. This is the first time I remember "divestiture" being mentioned which is selling it as opposed to spinning out. Seems like they have a lot of options they are considering. Will be interesting which path they take - spinoff or divestiture. Could explain how they will be able to fund all the other initiatives.

12:20 - Were as part of our incubation model we are now preparing to monetize this asset either through spinoff or divestiture. We ..., we're at various stages of discussions with various groups with respect to these monetizing this asset and we expect to update the market in the near future regarding our plans with this asset. We see this as a huge opportunity so we have a lot of options in terms of how we are going to go about this product.